Adcock Ingram Holdings Limited
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products… Read more
Market Cap & Net Worth: Adcock Ingram Holdings Limited (AIHLF)
Adcock Ingram Holdings Limited (PINK:AIHLF) has a market capitalization of $359.57 Million ($359.57 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #18868 globally and #6988 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Adcock Ingram Holdings Limited's stock price $2.45 by its total outstanding shares 146762866 (146.76 Million).
Adcock Ingram Holdings Limited Market Cap History: 2015 to 2025
Adcock Ingram Holdings Limited's market capitalization history from 2015 to 2025. Data shows growth from $15.72 Million to $359.57 Million (39.20% CAGR).
Adcock Ingram Holdings Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Adcock Ingram Holdings Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.04x
Adcock Ingram Holdings Limited's market cap is 0.04 times its annual revenue
1.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
0.42x
Adcock Ingram Holdings Limited's market cap is 0.42 times its annual earnings
10.29x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $20.34 Million | $5.55 Billion | $168.80 Million | 0.00x | 0.12x |
| 2017 | $20.84 Million | $5.94 Billion | $553.53 Million | 0.00x | 0.04x |
| 2018 | $21.50 Million | $6.38 Billion | $637.94 Million | 0.00x | 0.03x |
| 2019 | $21.85 Million | $7.08 Billion | $687.99 Million | 0.00x | 0.03x |
| 2020 | $22.18 Million | $7.35 Billion | $676.37 Million | 0.00x | 0.03x |
| 2021 | $25.39 Million | $7.78 Billion | $657.46 Million | 0.00x | 0.04x |
| 2022 | $59.47 Million | $8.71 Billion | $800.35 Million | 0.01x | 0.07x |
| 2023 | $165.33 Million | $9.13 Billion | $898.41 Million | 0.02x | 0.18x |
| 2024 | $359.57 Million | $9.64 Billion | $814.01 Million | 0.04x | 0.44x |
| 2025 | $359.57 Million | $9.76 Billion | $858.51 Million | 0.04x | 0.42x |
Competitor Companies of AIHLF by Market Capitalization
Companies near Adcock Ingram Holdings Limited in the global market cap rankings as of March 18, 2026.
Key companies related to Adcock Ingram Holdings Limited by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #423 globally with a market cap of $51.97 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #455 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #423 | Zoetis Inc | NYSE:ZTS | $51.97 Billion | $118.15 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.46 |
| #455 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Adcock Ingram Holdings Limited Historical Marketcap From 2015 to 2025
Between 2015 and today, Adcock Ingram Holdings Limited's market cap moved from $15.72 Million to $ 359.57 Million, with a yearly change of 39.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $359.57 Million | 0.00% |
| 2024 | $359.57 Million | +117.49% |
| 2023 | $165.33 Million | +178.01% |
| 2022 | $59.47 Million | +134.22% |
| 2021 | $25.39 Million | +14.49% |
| 2020 | $22.18 Million | +1.48% |
| 2019 | $21.85 Million | +1.64% |
| 2018 | $21.50 Million | +3.17% |
| 2017 | $20.84 Million | +2.45% |
| 2016 | $20.34 Million | +29.41% |
| 2015 | $15.72 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Adcock Ingram Holdings Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $359.57 Million USD |
| MoneyControl | $359.57 Million USD |
| MarketWatch | $359.57 Million USD |
| marketcap.company | $359.57 Million USD |
| Reuters | $359.57 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.